China Resources Double-Crane Pharmaceutical (600062.SH): Lidocaine Hydrochloride Gel has obtained a drug registration certificate.
China Resources Double Crane (600062.SH) announced that it recently received the "Drug Registration Certificate" for Lidocaine Hydrochloride Gel issued by the National Medical Products Administration. This drug is suitable for local anesthesia during procedures requiring regional anesthesia, such as examinations and treatments performed via the urethra.
China Resources Double-Crane Pharmaceutical (600062.SH) announced that it recently received the Drug Registration Certificate for Lidocaine Hydrochloride Gel issued by the National Medical Products Administration. This medication is suitable for local anesthesia required for local anesthetic procedures and examinations and treatments performed via the urethra.
Related Articles
CHINA TIANRUI (01252): Zhonghui Anda resigns as auditor
LEMO SERVICES (02539) announced its mid-term results, with net profit attributable to shareholders of 36.749 million yuan, a year-on-year decrease of 3.2%.
SBT Ultrasonic Technology (688392.SH) has received approval from the Shanghai Stock Exchange for its application to issue A-shares to specific targets.
CHINA TIANRUI (01252): Zhonghui Anda resigns as auditor
LEMO SERVICES (02539) announced its mid-term results, with net profit attributable to shareholders of 36.749 million yuan, a year-on-year decrease of 3.2%.
SBT Ultrasonic Technology (688392.SH) has received approval from the Shanghai Stock Exchange for its application to issue A-shares to specific targets.
RECOMMEND
